In Vivo Trafficking of the Anticancer Drug Tris(8-Quinolinolato) Gallium (III) (KP46) by Gallium-68/67 PET/SPECT Imaging [PDF]
KP46 (tris(hydroxyquinolinato)gallium(III)) is an experimental, orally administered anticancer drug. Its absorption, delivery to tumours, and mode of action are poorly understood. We aimed to gain insight into these issues using gallium-67 and gallium-68
Afnan M. F. Darwesh +9 more
doaj +3 more sources
Evaluation of Cyclotron Solid Target Produced Gallium-68 Chloride for the Labeling of [68Ga]Ga-PSMA-11 and [68Ga]Ga-DOTATOC [PDF]
Gallium-68 is a widely used positron-emitting radionuclide in nuclear medicine, traditionally obtained from 68Ge/68Ga generators. However, increasing clinical demand has driven interest in alternative production methods, such as medical cyclotrons ...
Michał Jagodziński +8 more
doaj +3 more sources
Comparison of the dosimetry of scandium-43 and scandium-44 patient organ doses in relation to commonly used gallium-68 for imaging neuroendocrine tumours [PDF]
Background Several research groups have explored the potential of scandium radionuclides for theragnostic applications due to their longer half-lives and equal or similar coordination chemistry between their diagnostic and therapeutic counterparts, as ...
Carlos Vinícius Gomes +8 more
doaj +4 more sources
Failure of Gallium-68 citrate to detect large, enhancing, intracerebral central nervous system tuberculomas: A cautionary tale [PDF]
Background: Gallium-68 citrate is an emerging diagnostic tool for the evaluation of infections. Its performance in brain infections is unknown. The available diagnostics for central nervous system tuberculosis are imprecise.
Selwyn Selva Kumar +4 more
doaj +2 more sources
Squamous cell carcinoma diagnosed as a suspected neuroendocrine tumor by gallium-68 DOTA-Tyr-octreotate positron emission tomography scan: A case report [PDF]
Gallium-68 DOTA-Tyr 3 -octreotate positron emission tomography scan is an important radiologic tool for detecting neuroendocrine tumors. It detects neoplasms by capturing the tumor’s increased density of somatostatin receptor expression.
Tori Johnson +3 more
doaj +2 more sources
A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein [PDF]
Background Fibroblast activation protein (FAP) targeting radiotracers have emerged as promising agents for cancer imaging and therapy. Recent advancements have focused on optimizing these agents for better tumor targeting and enhanced theranostic ...
Chengde Xie +11 more
doaj +2 more sources
Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease [PDF]
Gallium-68 fibroblast activation protein inhibitor [(68Ga)Ga-FAPI] is a new radiopharmaceutical positioning itself as the preferred agent in patients with malignant tumours, competing with 2-Deoxy-2-[18F]fluoro-d-glucose [2-(18F)FDG] using positron ...
Dineo Mpanya +11 more
doaj +2 more sources
Implementation of positron emission tomography radiopharmaceuticals labeled with Gallium-68 in a hospital radiopharmacy: experience with more than 7,500 patients [PDF]
In this study, we report the implementation of in-house synthesis of gallium-68 (68Ga)-labeled radiopharmaceuticals for positron emission tomography (PET) at a tertiary hospital radiopharmacy.
Lilian Yuri Itaya Yamaga +11 more
doaj +2 more sources
Side by side comparison of NOTA and DOTA for conjugation efficiency, gallium-68 labeling, and in vivo biodistribution of anti-mesothelin sdAb A1-His [PDF]
Background Mesothelin is a glycoprotein overexpressed in various cancers, with limited expression in healthy tissues. The single-domain antibody (sdAb, or nanobody) A1-His has previously successfully been validated in mice for the SPECT imaging of ...
Émilien N’Guessan +10 more
doaj +2 more sources
Development of a versatile [68Ga]Ga-FAPI-46 automated synthesis suitable to multi-elutions of germanium-68/gallium-68 generators [PDF]
Gallium-68-labeled FAPI-46 has recently been proposed as a novel positron emission tomography imaging probe to diagnose and monitor a wide variety of cancers.
Louis-Paul Paty +13 more
doaj +2 more sources

